Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT02406105Phase 2Unknown
Phase 2, open-label, single-arm trial, sponsored by Maria Skłodowska-Curie National Research Institute of Oncology. Primary endpoint: Tremor reduction evaluated using Unified Parkinson's Disease Rating Scale at 1 year. Status: unknown.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT02406105.